Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Experimental autoimmune encephalomyelitis in the mouse.
Mouse models for multiple sclerosis: historical facts and future implications.
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial.
Episode 64 with Dr. Helen Tremlett on pediatric MS and the gut microbiome
'Strikingly' Lower Familial Risk of MS Seen
Episode 68 with Dr. Philip De Jager on the state of MS genetics
ECTRIMS 2013 Day 4
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
MS Research Roundup: November 5, 2014
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
Harry Lee Parker and paroxysmal dysarthria and ataxia.
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
Episode 66 with Dr. Jeremy Hobart on optimizing treatment outcomes
CellCept (Product Insert)
Keystone Symposia Conference: Autoimmunity and Tolerance
Teriflunomide Gets High Marks in Yet Another Phase 3 Trial
CellCept Drug Details
Support MSDF
Precision medicine in chronic disease management: The MS BioScreen.
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
Rapidly progressive cerebellar ataxia in West Wales.
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »
